Integer Holdings Corporation

NYSE:ITGR Stock Report

Market Cap: US$4.7b

Integer Holdings Valuation

Is ITGR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ITGR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
US$445.09
Fair Value
67.8% undervalued intrinsic discount
8
Number of Analysts

Below Fair Value: ITGR ($143.28) is trading below our estimate of fair value ($445.09)

Significantly Below Fair Value: ITGR is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ITGR?

Key metric: As ITGR is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ITGR. This is calculated by dividing ITGR's market cap by their current earnings.
What is ITGR's PE Ratio?
PE Ratio41.3x
EarningsUS$116.40m
Market CapUS$4.74b

Price to Earnings Ratio vs Peers

How does ITGR's PE Ratio compare to its peers?

The above table shows the PE ratio for ITGR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average112.2x
LIVN LivaNova
111.9x48.2%US$2.6b
MASI Masimo
114.5x41.5%US$9.3b
INSP Inspire Medical Systems
170.1x30.8%US$5.7b
LMAT LeMaitre Vascular
52.4x12.2%US$2.2b
ITGR Integer Holdings
41.3x21.5%US$4.7b

Price-To-Earnings vs Peers: ITGR is good value based on its Price-To-Earnings Ratio (41.3x) compared to the peer average (112.2x).

Price to Earnings Ratio vs Industry

How does ITGR's PE Ratio compare vs other companies in the US Medical Equipment Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
MHUA Meihua International Medical Technologies
0.8xn/aUS$7.91m
PAVM PAVmed
0.5x-90.0%US$6.48m
UTRS Minerva Surgical
n/an/aUS$8.00
No more companies available in this PE range
ITGR 41.3xIndustry Avg. 35.9xNo. of Companies6PE020406080100+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ITGR is expensive based on its Price-To-Earnings Ratio (41.3x) compared to the US Medical Equipment industry average (36.3x).

Price to Earnings Ratio vs Fair Ratio

What is ITGR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ITGR PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio41.3x
Fair PE Ratio30.6x

Price-To-Earnings vs Fair Ratio: ITGR is expensive based on its Price-To-Earnings Ratio (41.3x) compared to the estimated Fair Price-To-Earnings Ratio (30.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ITGR forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$143.28
US$146.88
+2.5%
6.0%US$163.00US$138.00n/a8
Jan ’26US$132.52
US$146.88
+10.8%
6.0%US$163.00US$138.00n/a8
Dec ’25US$140.50
US$140.14
-0.3%
4.0%US$147.00US$130.00n/a7
Nov ’25US$126.45
US$140.88
+11.4%
3.9%US$147.00US$130.00n/a8
Oct ’25US$127.19
US$135.75
+6.7%
5.0%US$145.00US$125.00n/a8
Sep ’25US$130.07
US$129.78
-0.2%
7.6%US$139.00US$106.00n/a9
Aug ’25US$116.16
US$129.78
+11.7%
7.6%US$139.00US$106.00n/a9
Jul ’25US$115.16
US$128.75
+11.8%
8.6%US$139.00US$103.00n/a8
Jun ’25US$121.24
US$128.75
+6.2%
8.6%US$139.00US$103.00n/a8
May ’25US$109.78
US$126.71
+15.4%
9.3%US$139.00US$103.00n/a7
Apr ’25US$115.99
US$115.71
-0.2%
11.9%US$137.00US$100.00n/a7
Mar ’25US$111.52
US$108.00
-3.2%
7.7%US$123.00US$100.00n/a6
Feb ’25US$103.83
US$102.20
-1.6%
4.1%US$106.00US$95.00n/a5
Jan ’25US$99.08
US$96.40
-2.7%
8.3%US$106.00US$86.00US$132.525
Dec ’24US$88.65
US$95.00
+7.2%
9.1%US$106.00US$86.00US$140.505
Nov ’24US$82.42
US$95.00
+15.3%
9.1%US$106.00US$86.00US$126.455
Oct ’24US$78.43
US$98.60
+25.7%
6.9%US$106.00US$88.00US$127.195
Sep ’24US$85.01
US$99.67
+17.2%
6.7%US$106.00US$88.00US$130.076
Aug ’24US$92.63
US$99.67
+7.6%
6.7%US$106.00US$88.00US$116.166
Jul ’24US$88.61
US$90.00
+1.6%
3.9%US$96.00US$86.00US$115.166
Jun ’24US$82.63
US$90.00
+8.9%
3.9%US$96.00US$86.00US$121.246
May ’24US$82.77
US$91.25
+10.2%
4.1%US$96.00US$86.00US$109.784
Apr ’24US$77.50
US$86.75
+11.9%
2.2%US$90.00US$85.00US$115.994
Mar ’24US$76.53
US$87.00
+13.7%
2.5%US$90.00US$85.00US$111.523
Feb ’24US$68.95
US$87.00
+26.2%
3.4%US$90.00US$84.00US$103.832
Jan ’24US$68.46
US$87.00
+27.1%
3.4%US$90.00US$84.00US$99.082
Analyst Price Target
Consensus Narrative from 8 Analysts
US$146.88
Fair Value
2.4% undervalued intrinsic discount
8
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/23 05:33
End of Day Share Price 2025/01/23 00:00
Earnings2024/09/27
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Integer Holdings Corporation is covered by 21 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Robert WassermanBenchmark Company
Craig BijouBofA Global Research